Immunological functions of hyaluronan and its receptors in the lymphatics

Immunological Reviews

Volumn 230, Issue 1, 2009, Pages 216-231

  Jackson, David G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CD44; Hyaluronan; Lymphatic endothelium; LYVE 1; Transmigration

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; HUMAN; IMMUNOSURVEILLANCE; LEUKOCYTE MIGRATION; LYMPH NODE; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIALYLATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD44; CYTOKINES; ENDOTHELIUM; GLYCOPROTEINS; HUMANS; HYALURONIC ACID; LYMPHATIC SYSTEM; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; VESICULAR TRANSPORT PROTEINS;

EID: 67649756857     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2009.00803.x     Document Type: Review

References (139)

1. Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev 2001 50 : 3 20. (Pubitemid 32727274)
2. Oliver G, Alitalo K. The lymphatic vasculature: recent progress and paradigms. Annu Rev Cell Dev Biol 2005 21 : 457 483. (Pubitemid 41740643)
3. Srinivasan RS, et al. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev 2007 21 : 2422 2432. (Pubitemid 47529372)
4. Mortimer PS, Levick JR. Chronic peripheral oedema: the critical role of the lymphatic system. Clin Med 2004 4 : 448 453. (Pubitemid 39457274)
5. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003 3 : 867 878. (Pubitemid 37411716)
6. Johnson LA, Jackson DG. Cell traffic and the lymphatic endothelium. Ann NY Acad Sci 2008 1131 : 119 133. (Pubitemid 351758509)
7. Swartz MA, Hubbell JA, Reddy ST. Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design. Semin Immunol 2008 20 : 147 156.
8. Junt T, et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 2007 450 : 110 114. (Pubitemid 350070574)
9. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 2005 5 : 617 628. (Pubitemid 41113193)
10. Randolph GJ, Ochando J, Partida-Sanchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008 26 : 293 316. (Pubitemid 351600378)
11. Teoh D, Johnson LA, Hanke T, McMichael AJ, Jackson DG. Blocking development of a CD8+ T cell response by targeting lymphatic recruitment of APC. J Immunol 2009 182 : 2425 2431.
12. Leak LV. The structure of lymphatic capillaries in lymph formation. Fed Proc 1976 35 : 1863 1871.
13. Weber E, Rossi A, Solito R, Sacchi G, Agliano M, Gerli R. Focal adhesion molecules expression and fibrillin deposition by lymphatic and blood vessel endothelial cells in culture. Microvasc Res 2002 64 : 47 55. (Pubitemid 34713230)
14. Gerli R, Ibba L, Fruschelli C. Ultrastructural cytochemistry of anchoring filaments of human lymphatic capillaries and their relation to elastic fibers. Lymphology 1991 24 : 105 112.
15. Stoitzner P, Pfaller K, Stossel H, Romani N. A close-up view of migrating Langerhans cells in the skin. J Invest Dermatol 2002 118 : 117 125. (Pubitemid 34107432)
16. Stoitzner P, et al. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J Invest Dermatol 2003 120 : 266 274. (Pubitemid 36513077)
17. Aziz KA. CD44 mediates polymorphonuclear leukocyte motility on hyaluronan. Saudi Med J 2003 24 : 827 831. (Pubitemid 37160624)
18. Azzali G. Structure, lymphatic vascularization and lymphocyte migration in mucosa-associated lymphoid tissue. Immunol Rev 2003 195 : 178 189. (Pubitemid 37153461)
19. Azzali G. On the transendothelial passage of tumor cell from extravasal matrix into the lumen of absorbing lymphatic vessel. Microvasc Res 2006 72 : 74 85. (Pubitemid 44137376)
20. Baluk P, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 2007 204 : 2349 2362. (Pubitemid 47529321)
21. Lynch PM, Delano FA, Schmid-Schonbein GW. The primary valves in the initial lymphatics during inflammation. Lymphat Res Biol 2007 5 : 3 10. (Pubitemid 46753894)
22. Chan VW, et al. Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells. Blood 1999 93 : 3610 3616. (Pubitemid 29249805)
23. Kellermann SA, Hudak S, Oldham ER, Liu YJ, McEvoy LM. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol 1999 162 : 3859 3864. (Pubitemid 29314763)
24. Forster R, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999 99 : 23 33. (Pubitemid 29468627)
25. Saeki H, Moore AM, Brown MJ, Hwang ST. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 1999 162 : 2472 2475. (Pubitemid 29309263)
26. Ohl L, et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004 21 : 279 288. (Pubitemid 39094056)
27. Kabashima K, et al. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am J Pathol 2007 171 : 1249 1257. (Pubitemid 47582898)
28. Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008 8 : 362 371. (Pubitemid 351595218)
29. Ouwehand K, Santegoets SJ, Bruynzeel DP, Scheper RJ, de Gruijl TD, Gibbs S. CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur J Immunol 2008 38 : 3050 3059.
30. Randolph GJ. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin Immunol 2001 13 : 267 274. (Pubitemid 32744577)
31. Mori S, Nakano H, Aritomi K, Wang CR, Gunn MD, Kakiuchi T. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J Exp Med 2001 193 : 207 218.
32. Gunn MD, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999 189 : 451 460. (Pubitemid 29187367)
33. Johnson LA, Clasper S, Holt AP, Lalor PF, Baban D, Jackson DG. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 2006 203 : 2763 2777. (Pubitemid 44833351)
34. Van VQ, et al. Expression of the self-marker CD47 on dendritic cells governs their trafficking to secondary lymphoid organs. EMBO J 2006 25 : 5560 5568.
35. Maddaluno L, et al. The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells. J Exp Med 2009 206 : 623 635.
36. Ledgerwood LG, et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol 2008 9 : 42 53. (Pubitemid 350286203)
37. Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med 2000 192 : 1425 1440.
38. Palframan RT, et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 2001 194 : 1361 1373. (Pubitemid 33055053)
39. Allen JM, McHale NG. Neuromuscular transmission in bovine mesenteric lymphatics. Microvasc Res 1986 31 : 77 83. (Pubitemid 16132535)
40. McHale NG, Meharg MK. Co-ordination of pumping in isolated bovine lymphatic vessels. J Physiol 1992 450 : 503 512.
41. McHale NG. The lymphatic circulation. Ir J Med Sci 1992 161 : 483 486.
42. Muthuchamy M, Zawieja D. Molecular regulation of lymphatic contractility. Ann NY Acad Sci 2008 1131 : 89 99. (Pubitemid 351758506)
43. Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, Swartz MA. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 2007 11 : 526 538. (Pubitemid 46856909)
44. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004 4 : 528 539. (Pubitemid 38868622)
45. Day AJ, Prestwich GD. Hyaluronan-binding proteins: tying up the giant. J Biol Chem 2002 277 : 4585 4588. (Pubitemid 34968483)
46. Li Y, Toole BP, Dealy CN, Kosher RA. Hyaluronan in limb morphogenesis. Dev Biol 2007 305 : 411 420. (Pubitemid 46686606)
47. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992 6 : 2397 2404.
48. Laurent TC, Laurent UB, Fraser JR. Functions of hyaluronan. Ann Rheum Dis 1995 54 : 429 432.
49. McKee CM, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996 98 : 2403 2413. (Pubitemid 26394217)
50. Termeer CC, et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000 165 : 1863 1870. (Pubitemid 30643136)
51. Slevin M, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002 277 : 41046 41059. (Pubitemid 35215695)
52. Slevin M, Krupinski J, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 1998 78 : 987 1003. (Pubitemid 28378213)
53. Termeer C, et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002 195 : 99 111. (Pubitemid 34074500)
54. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004 279 : 17079 17084. (Pubitemid 38560463)
55. Liang J, et al. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol 2007 178 : 2469 2475. (Pubitemid 46233447)
56. Kawana H, et al. CD44 suppresses TLR-mediated inflammation. J Immunol 2008 180 : 4235 4245.
57. Lebel L, Smith L, Risberg B, Laurent TC, Gerdin B. Increased lymphatic elimination of interstitial hyaluronan during E. coli sepsis in sheep. Am J Physiol 1989 256 : H1524 H1531.
58. Reed RK, Laurent UB. Turnover of hyaluronan in the microcirculation. Am Rev Respir Dis 1992 146 : S37 S39.
59. Reed RK, Laurent UB, Fraser JR, Laurent TC. Removal rate of [3H]hyaluronan injected subcutaneously in rabbits. Am J Physiol 1990 259 : H532 H535.
60. Reed RK, Lilja K, Laurent TC. Hyaluronan in the rat with special reference to the skin. Acta Physiol Scand 1988 134 : 405 411. (Pubitemid 18268552)
61. Berg S, Brodin B, Hesselvik F, Laurent TC, Maller R. Elevated levels of plasma hyaluronan in septicaemia. Scand J Clin Lab Invest 1988 48 : 727 732. (Pubitemid 19005818)
62. Berg S, Engman A, Holmgren S, Lundahl T, Laurent TC. Increased plasma hyaluronan in severe pre-eclampsia and eclampsia. Scand J Clin Lab Invest 2001 61 : 131 137.
63. Ferrara JJ, et al. Increased hyaluronan flux from skin following burn injury. J Surg Res 1991 50 : 240 244.
64. Laurent TC, Laurent UB, Fraser JR. Serum hyaluronan as a disease marker. Ann Med 1996 28 : 241 253. (Pubitemid 26191062)
65. Chockalingam PS, Zeng W, Morris EA, Flannery CR. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2). Arthritis Rheum 2004 50 : 2839 2848. (Pubitemid 39209521)
66. Greenwald RA, Moak SA. Degradation of hyaluronic acid by polymorphonuclear leukocytes. Inflammation 1986 10 : 15 30. (Pubitemid 16170308)
67. Knudson W, Chow G, Knudson CB. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol 2002 21 : 15 23. (Pubitemid 34100818)
68. Armstrong SE, Bell DR. Relationship between lymph and tissue hyaluronan in skin and skeletal muscle. Am J Physiol Heart Circ Physiol 2002 283 : H2485 H2494.
69. Armstrong SE, Bell DR. Ischemia-reperfusion does not cause significant hyaluronan depolymerization in skeletal muscle. Microvasc Res 2002 64 : 353 362.
70. Falkowski M, Schledzewski K, Hansen B, Goerdt S. Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces. Histochem Cell Biol 2003 120 : 361 369. (Pubitemid 38005355)
71. Politz O, et al. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 2002 362 : 155 164. (Pubitemid 34174473)
72. Martens JH, et al. Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J Pathol 2006 208 : 574 589.
73. Harris EN, Weigel JA, Weigel PH. Endocytic function, glycosaminoglycan specificity, and antibody sensitivity of the recombinant human 190-kDa hyaluronan receptor for endocytosis (HARE). J Biol Chem 2004 279 : 36201 36209. (Pubitemid 39128955)
74. Harris EN, Kyosseva SV, Weigel JA, Weigel PH. Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE). J Biol Chem 2007 282 : 2785 2797. (Pubitemid 47084328)
75. Harada H, Takahashi M. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem 2007 282 : 5597 5607. (Pubitemid 47093756)
76. Tammi R, et al. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem 2001 276 : 35111 35122.
77. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 2004 83 : 317 325. (Pubitemid 39307169)
78. Johnson LA, Prevo R, Clasper S, Jackson DG. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J Biol Chem 2007 282 : 33671 33680. (Pubitemid 350159526)
79. Pegu A, Qin S, Fallert Junecko BA, Nisato RE, Pepper MS, Reinhart TA. Human lymphatic endothelial cells express multiple functional TLRs. J Immunol 2008 180 : 3399 3405.
80. Shimada M, et al. Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization. Development 2008 135 : 2001 2011. (Pubitemid 351943364)
81. Mummert ME, Mohamadzadeh M, Mummert DI, Mizumoto N, Takashima A. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J Exp Med 2000 192 : 769 779. (Pubitemid 30737584)
82. Mummert DI, Takashima A, Ellinger L, Mummert ME. Involvement of hyaluronan in epidermal Langerhans cell maturation and migration in vivo. J Dermatol Sci 2003 33 : 91 97. (Pubitemid 37315901)
83. Kaya G, Rodriguez I, Jorcano JL, Vassalli P, Stamenkovic I. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev 1997 11 : 996 1007. (Pubitemid 27199879)
84. Kaya G, Rodriguez I, Jorcano JL, Vassalli P, Stamenkovic I. Cutaneous delayed-type hypersensitivity response is inhibited in transgenic mice with keratinocyte-specific CD44 expression defect. J Invest Dermatol 1999 113 : 137 138. (Pubitemid 29328173)
85. Mummert DI, Takashima A, Mummert ME. Langerhans cells in CD44-deficient mice emigrate from the epidermis but fail to reach the lymph nodes after hapten application. J Invest Dermatol 2004 122 : 846 847. (Pubitemid 38471358)
86. Mummert ME, Mummert D, Edelbaum D, Hui F, Matsue H, Takashima A. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J Immunol 2002 169 : 4322 4331. (Pubitemid 35178205)
87. Mahaffey CL, Mummert ME. Hyaluronan synthesis is required for IL-2-mediated T cell proliferation. J Immunol 2007 179 : 8191 8199.
88. Schmits R, et al. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997 90 : 2217 2233. (Pubitemid 27392706)
89. Banerji S, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999 144 : 789 801. (Pubitemid 29234556)
90. Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 2001 276 : 19420 19430.
91. Jackson DG, Prevo R, Clasper S, Banerji S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001 22 : 317 321. (Pubitemid 32675245)
92. Levesque MC, Haynes BF. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J Immunol 1996 156 : 1557 1565. (Pubitemid 26065867)
93. Levesque MC, Haynes BF. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13. J Immunol 1997 159 : 6184 6194. (Pubitemid 127471559)
94. Lesley J, Howes N, Perschl A, Hyman R. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J Exp Med 1994 180 : 383 387. (Pubitemid 24181089)
95. Lesley J, Hyman R. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur J Immunol 1992 22 : 2719 2723.
96. Trowbridge IS, Lesley J, Schulte R, Hyman R, Trotter J. Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 1982 15 : 299 312.
97. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997 278 : 672 675. (Pubitemid 27464963)
98. DeGrendele HC, Kosfiszer M, Estess P, Siegelman MH. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 1997 159 : 2549 2553. (Pubitemid 127681269)
99. Siegelman MH, DeGrendele HC, Estess P. Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol 1999 66 : 315 321. (Pubitemid 29379176)
100. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001 7 : 213 221. (Pubitemid 32822893)
101. Mikecz K, Dennis K, Shi M, Kim JH. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum 1999 42 : 659 668. (Pubitemid 29171985)
102. Mohamadzadeh M, DeGrendele H, Arizpe H, Estess P, Siegelman M. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest 1998 101 : 97 108. (Pubitemid 28058908)
103. Brown KL, Maiti A, Johnson P. Role of sulfation in CD44-mediated hyaluronan binding induced by inflammatory mediators in human CD14(+) peripheral blood monocytes. J Immunol 2001 167 : 5367 5374. (Pubitemid 33014339)
104. Delcommenne M, Kannagi R, Johnson P. TNF-alpha increases the carbohydrate sulfation of CD44: induction of 6-sulfo N-acetyl lactosamine on N- and O-linked glycans. Glycobiology 2002 12 : 613 622. (Pubitemid 35214823)
105. Johnson P, Maiti A, Brown KL, Li R. A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response? Biochem Pharmacol 2000 59 : 455 465. (Pubitemid 30045583)
106. Maiti A, Maki G, Johnson P. TNF-alpha induction of CD44-mediated leukocyte adhesion by sulfation. Science 1998 282 : 941 943. (Pubitemid 28507526)
107. Hyman R, Lesley J, Schulte R. Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding. Immunogenetics 1991 33 : 392 395.
108. Lesley J, English N, Perschl A, Gregoroff J, Hyman R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 1995 182 : 431 437.
109. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 1995 182 : 419 429.
110. English NM, Lesley JF, Hyman R. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res 1998 58 : 3736 3742. (Pubitemid 28376577)
111. Katoh S, et al. Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol 1999 162 : 5058 5061. (Pubitemid 29307104)
112. Gee K, Kozlowski M, Kumar A. Tumor necrosis factor-alpha induces functionally active hyaluronan-adhesive CD44 by activating sialidase through p38 mitogen-activated protein kinase in lipopolysaccharide-stimulated human monocytic cells. J Biol Chem 2003 278 : 37275 37287. (Pubitemid 37175244)
113. Razi N, Varki A. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci USA 1998 95 : 7469 7474. (Pubitemid 28293276)
114. Razi N, Varki A. Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. Glycobiology 1999 9 : 1225 1234.
115. Teriete P, et al. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol Cell 2004 13 : 483 496. (Pubitemid 38299377)
116. Nightingale TD, Banerji S, Jackson DG. Functional regulation of the lymphatic endothelial hyaluronan receptor LYVE-1: The role of N-glycosylation. In : Balazs EAaH VC ed. Hyaluronan, Structure, Metabolism, Biological Activities, Therapeutic Applications, I edn. New Jersey : Matrix Biology Institute, 2005 : 615 618.
117. Nightingale TD, Frayne ME, Clasper S, Banerji S, Jackson DG. A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium. J Biol Chem 2009 284 : 3935 3945.
118. Xia L, et al. Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans. J Cell Biol 2004 164 : 451 459. (Pubitemid 38174772)
119. Fu J, et al. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest 2008 118 : 3725 3737.
120. Brissett NC, Perkins SJ. The protein fold of the hyaluronate-binding proteoglycan tandem repeat domain of link protein, aggrecan and CD44 is similar to that of the C-type lectin superfamily. FEBS Lett 1996 388 : 211 216. (Pubitemid 26226363)
121. Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J 1992 6 : 861 870.
122. Kohda D, et al. Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell 1996 86 : 767 775. (Pubitemid 26303445)
123. Jackson DG. The lymphatic endothelial hyaluronan receptor LYVE-1. Glycoforum wwwglycoforumgrjp/science/hyaluronan/HA28/HA28Ehtml, 2004.
124. Banerji S, et al. Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat Struct Mol Biol 2007 14 : 234 239. (Pubitemid 46355571)
125. Torgersen D, Mullin NP, Drickamer K. Mechanism of ligand binding to E- and P-selectin analyzed using selectin/mannose-binding protein chimeras. J Biol Chem 1998 273 : 6254 6261. (Pubitemid 28144713)
126. Bouyain S, Rushton S, Drickamer K. Minimal requirements for the binding of selectin ligands to a C-type carbohydrate-recognition domain. Glycobiology 2001 11 : 989 996. (Pubitemid 34048631)
127. Watanabe H, Cheung SC, Itano N, Kimata K, Yamada Y. Identification of hyaluronan-binding domains of aggrecan. J Biol Chem 1997 272 : 28057 28065.
128. Seyfried NT, McVey GF, Almond A, Mahoney DJ, Dudhia J, Day AJ. Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican: formation of ternary complexes with defined hyaluronan oligosaccharides. J Biol Chem 2005 280 : 5435 5448. (Pubitemid 40280019)
129. Day AJ, de la Motte CA. Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol 2005 26 : 637 643. (Pubitemid 41628196)
130. Zhuo L, Hascall VC, Kimata K. Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex. J Biol Chem 2004 279 : 38079 38082.
131. de La Motte CA, Hascall VC, Calabro A, Yen-Lieberman B, Strong SA. Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C). J Biol Chem 1999 274 : 30747 30755.
132. de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, Strong SA. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 2003 163 : 121 133. (Pubitemid 36759597)
133. Majors AK, et al. Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion. J Biol Chem 2003 278 : 47223 47231. (Pubitemid 37452309)
134. Selbi W, de la Motte CA, Hascall VC, Day AJ, Bowen T, Phillips AO. Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney Int 2006 70 : 1287 1295. (Pubitemid 44435180)
135. Lauer ME, Mukhopadhyay D, Fulop C, de la Motte CA, Majors AK, Hascall VC. Primary murine airway smooth muscle cells exposed to poly(I,C) or tunicamycin synthesize a leukocyte-adhesive hyaluronan matrix. J Biol Chem 2009 284 : 5299 5312.
136. Lesley J, et al. TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J Biol Chem 2004 279 : 25745 25754.
137. Zhuo L, et al. SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum. J Biol Chem 2006 281 : 20303 20314.
138. Valenzuela DM, et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol 2003 21 : 652 659. (Pubitemid 36638092)
139. Gale NW, et al. Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1. Mol Cell Biol 2007 27 : 595 604. (Pubitemid 46080127)